Cargando…
Releasing the Immune System Brakes Using siRNAs Enhances Cancer Immunotherapy
Therapeutic dendritic cell (DC) cancer vaccines rely on the immune system to eradicate tumour cells. Although tumour antigen-specific T cell responses have been observed in most studies, clinical responses are fairly low, arguing for the need to improve the design of DC-based vaccines. The incorpora...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406640/ https://www.ncbi.nlm.nih.gov/pubmed/30717461 http://dx.doi.org/10.3390/cancers11020176 |